The Port Delivery System for Treating Diabetic Retinopathy
We discuss the use of the PDS in the treatment of diabetic retinopathy and diabetic macular edema with Professor Carl Regillo of the Wills Eye Hospital.
Sep 21, 2023•17 min•Ep. 114
Retina Synthesis
Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.
Last refreshed: ⓘ
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episodes
A Profile of Eugene de Juan, MD
Dr. Eugene de Juan, winner of this year's ASRS Pyron Award, joins us to discuss his career highlights. Dr. de Juan is CEO of Forsight Labs and Professor of Ophthalmology, University of California, San Francisco.
Sep 14, 2023•20 min•Ep. 113
An Implantation Telescope for Macular Disease
We discuss the use of an improved implantable telescope as a low vision aid in patients with macular disease with Dr. David Almeida, Erie Retina Research.
Aug 31, 2023•9 min•Ep. 111
Prevention of Vision Loss in the Gather Trial of IZERVAY
We discuss the prevention of vision loss in the Gather 2 trial of IZERVAY with Dr. Carl Danzig of the Rand Eye Institute, Pompano Beach, Florida
Aug 24, 2023•12 min•Ep. 110
GALE Long Term Extension Study for GA
We discuss a 30-Month Outcome with Pegcetacoplan for the Treatment of Geographic Atrophy with Nathan Steinle MD, California Retina Consultants, Santa Barbara, California.
Aug 14, 2023•18 min•Ep. 109
Pegcetacoplan (SYFOVRE) Clinical Update
We discuss the latest information on Safety & Efficacy in Clinic and Clinical Trials with Cedric Francois, MD, PhD.
Aug 11, 2023•18 min•Ep. 108
Faricimab in Neovascular AMD
We discuss the latest information on the use of faricimab in neovascular AMD with Dr. Yasha Modi, Associate Professor of Ophthalmology, NYU Langone Medical Center.
Aug 03, 2023•17 min•Ep. 107
High Dose Aflibercept for Neovascular AMD
We discuss the use of high dose aflibercept for the treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor, Roski Eye Institute of USC.
Jul 27, 2023•16 min•Ep. 106
Pegcetacoplan for Geographic Atrophy Update
We discuss the latest information on the use of pegcetacoplan for geographic atrophy in AMD with Dr. Dilsher Dhoot, California Retinal Consultants.
Jul 20, 2023•12 min•Ep. 105
Ocular Therapeutix: A TKI and Hydrogel Implant
We discuss the use of a novel drug (tyrosine kinase inhibitor) and novel delivery system (hydrogel) for the treatment of neovascular AMD with Dr. Peter Kaiser of the Cleveland Clinic.
Jul 13, 2023•23 min•Ep. 104
Biosimilar Drugs for Retinal Diseases
We discuss the use of biosimilar drugs for retinal diseases with Dr. Arghavan Almony, author of definitive monograph of these agents.
Jul 06, 2023•24 min•Ep. 103
Faricimab vs Aflibercept in Diabetic Macular Edema
In our latest update, we discuss the relative drying effects of faricimab and aflibercept in the treatment of diabetic macular edema with Dr. Roger Goldberg.
Jun 29, 2023•16 min•Ep. 102
Artificial Intelligence in the Management of Geographic Atrophy
In our latest update, we discuss the use of artificial intelligence in the management of geographic atrophy with Professor Pearse Keane, Moorfields Eye Hospital, London.
Jun 22, 2023•16 min•Ep. 101
Molecular Diagnostics in the Diagnosis and Treatment of Uveal Melanoma
In our latest update, we discuss the use of molecular techniques in the management of uveal melanoma with Dr. William Harbour, Professor and Chair, Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas.
Jun 15, 2023•18 min•Ep. 100
Faricimab in the Treatment of Retinal Venous Occlusion
We discuss the results of clinical trials studying the use of faricimab in the treatment of retinal venous occlusion with Dr. Ramin Tadayoni, Professor of Ophthalmology University of Paris.
Jun 08, 2023•8 min•Ep. 99
The Use of High Dose Aflibercept in Diabetic Macular Edema
We review the one year results of a clinical trial using high dose aflibercept (8mg) for the treatment of diabetic macular edema with Dr. David Boyer, Adjunct Clinical Professor of Ophthalmology, USC Roski Eye Institute
Jun 01, 2023•11 min•Ep. 98
Widefield OCT Angiography
We the discuss the use of wide field OCT angiography in the management of diabetic retinopathy, retinal vein occlusion, and pediatric retinal disease with Dr. Amir Kashani, Associate Professor of Ophthalmology, Wilmer Eye Institute, Johns Hopkins School of Medicine
May 25, 2023•17 min•Ep. 97
Aflibercept Therapy of Retinopathy of Prematurity
We review the use of anti-VEGF therapy for retinopathy of prematurity and in particular, the results of a clinical trial employing aflibercept with Dr. Darius Moshfeghi, Professor of Ophthalmology, Director of the Retina Service, Byers Eye Institute, Stanford University School of Medicine.
May 18, 2023•12 min•Ep. 96
Home OCT in the Management of Neovascular AMD: Latest Development
We discuss the use of home OCT and artificial intelligence in the management of anti-VEGF therapy of neovascular AMD with Dr. Anat Loewenstein, Director, Department of Ophthalmology, Tel Aviv Medical Center, Israel.
May 11, 2023•15 min•Ep. 95
Suprachoroidal Corticosteroids for the Treatment of Macular Edema
We discuss the use of suprachoroidal triamcinolone for the treatment of macular edema with Dr. Steven Yeh, Truhlsen Chair of Ophthalmology, University of Nebraska School of Medicine.
May 04, 2023•11 min•Ep. 94
The Use of the Port Delivery System for the Treatment of Diabetic Macular Edema
We discuss the use of the port delivery system for the treatment of diabetic macular edema with Dr. Arshad Khanani, Director of Clinical Research, Sierra Eye Associates, Associate Clinical Professor, University of Nevada School of Medicine, Reno.
Apr 27, 2023•13 min•Ep. 93
Suprachoroidal Therapy of Neovascular AMD
We discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD with Dr. Mark Barakat, Assistant Clinical Professor of Ophthalmology, University of Arizona School of Medicine-Phoenix.
Apr 20, 2023•11 min•Ep. 92
Microperimetry in the Assessment of Geographic Macular Atrophy
We discuss the use of microperimetry to assess treatment effects of anti-complement therapy (Apellis) of geographic atrophy with Dr. Nadia Waheed, Associate Professor of Ophthalmology, New England Eye Center, Tufts University School of Medicine.
Apr 13, 2023•14 min•Ep. 91
Subretinal Gene Therapy for Neovascular AMD
We discuss the results of the RGX-314 study of subretinal gene therapy for neovascular AMD with Dr. Allen Ho, Professor of Ophthalmology, Wills Eye Hospital.
Apr 06, 2023•12 min•Ep. 90
A Tyrosine Kinase Inhibitor Implant for the Treatment of Neovascular AMD
In our latest update, We discuss the results of a one year Phase I trial exploring the use of a tyrosinase inhibitor in an hydrogel implant for the treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology, USC Roski Eye Institute.
Mar 30, 2023•18 min•Ep. 89
15 Year Results of Fixed Dose Anti-VEGF Treatment of Neovascular AMD
We discuss long term results of fixed dose anti-VEGF therapy for neovascular AMD with Dr. Ivan Suner, Retina Associates of Florida, Tampa, Florida.
Mar 23, 2023•14 min•Ep. 88
Dexamethasone Implant for Treating Diabetic Macular Edema
We discuss the use of corticosteroids, in particular, the dexamethasone implant in the management of diabetic macular edema with Dr. Kevin Blinder, Professor of Clinical Ophthalmology at Washington University School of Medicine, The Retina Institute.
Mar 16, 2023•18 min•Ep. 87
Retinal Vasculitis Update
Thomas Albini, MD, Professor of Clinical Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute provides a comprehensive review of the etiology, diagnostic evaluation and treatment of retinal vasculitis.
Mar 02, 2023•27 min•Ep. 86
Central Serous Chorioretinopathy
We discuss the latest developments in diagnostic evaluation and treatment of eyes with central serous chorioretinopathy. with Roger Goldberg, MD, Bay Area Retina Associates, Walnut Creek, CA
Feb 23, 2023•18 min•Ep. 85
Faricimab Update
Dr. Roger Goldberg from Bay Area Retina Associates, Walnut Creek, CA discusses the latest data regarding the use of faricimab in diabetic macular edema and neovascular AMD.
Feb 16, 2023•15 min•Ep. 84
Hosted on Buzzsprout
For the best experience, listen in Metacast app for iOS or Android